Abstract
Osteoarthritis is a degenerative and reparative process occurring in synovial joints. In the present study, collagen type I C-telopeptide (CTX) and procollagen type I N-terminal propeptide (P1NP) were measured in blood serum and synovial fluid of four cross-breed dogs with experimental CCL rupture. These biomarkers were selected as bone turnover biomarkers. The markers were measured on days 0, 14, 28, 90, and 180 post surgery. Statistical analysis showed significant increase in P1NP in both serum and synovial fluid. The CTX showed a significant increase in serum and a non significant increase in synovial fluid at the end of study. The changes in bone turnover biomarkers can be diagnostic in osteoarthritis. As time passes, the changes become more evident. Since the changes were the same in both serum and synovial fluid, measurement of the markers in serum is preferred as it is easier.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allen MJ (2003) Biochemical markers of bone metabolism in animals: uses and limitations. Vet Clin Pathol 32(3):101–113
Bijlsma JW, Berenbaum F, Lafeber FP (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377(9783):2115–2126
Bjarnason NH, Henriksen EEG, Alexandersen P, Christgau S, Henriksen DB, Christiansen C (2002) Mechanism of circadian variation in bone resorption. Bone 30:307–313
Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C (1997) Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 12(7):1028–1034
Civitelli R, Armamento-Villareal R, Napoli N (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 20(6):843–851
Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ (2011) The role of growth factors in cartilage repair. Clin Orthop Relat Res 469(10):2706–2715
Fujita Y, Hara Y, Nezu Y, Schulz KS, Tagawa M (2006) Proinflammatory cytokine activities, matrix metalloproteinase-3 activity, and sulfated glycosaminoglycan content in synovial fluid of dogs with naturally acquired cranial cruciate ligament rupture. Vet Surg 35(4):369–376
Garnero P, Vergnaud P, Hoyle N (2008) Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 54(1):188–196
Kellgren JH, Lawrence JS (1975) Radiological assessment of osteoarthrosis. Ann Rheum Dis 16:464–502
Liu SH, Yang RS, Al-Shaikh RBS, Lane JM (1995) Collagen in tendon, ligament, and bone healing: a current review. Clin Orthop Relat Res 318:265–278
Lüftner D, Jozereau D, Schildhauer S, Geppert R, Müller C, Fiolka G, Wernecke KD, Possinger K (2005) PINP as serum marker of metastatic spread to the bone in breast cancer patients. Anticancer Res 25(3A):1491–1499
Nikahval B, Hosseini Z, Nazifi S, Foroud M (2015) Evaluation of antioxidant enzymes changes in synovial fluid and blood, following experimental osteoarthritis in dogs. Comp Clin Pathol 24:23–27
Nikahval B, Nazifi S, Aliabadi F, Mansourian M, Imani H (2013) Measurement of interleukin 1B and Interleukin 6 in synovial fluid of osteoarthritic dogs. Bulgarian J Vet Med 16(4):282–288
Pond MJ, Nuki G (1973) Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis 32(4):387
Seibel MJ (2005) Biochemical markers of bone turnover part I: biochemistry and variability. Clin Biochem Rev 26(4):97–122
Stokes FJ, Ivanov P, Bailey LM, Fraser WD (2011) The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism. Clin Chem 57:138–140
Toivonen J, Tahtela R, Laitinen K, Risteli J, Valimaki MJ (1998) Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy. Eur J Endocrinol 138:667–673
Tymczyna B, Tatara MR, Krupski W, Tymczyna-Sobotka M, Łuszczewska-Sierakowska I, Bachanek T (2012) Relationships between biochemical bone metabolism indices and morphometric, densitometric and mechanical properties of mandible in 6-month-old pigs. Ann Agric Environ Med 19:535–539
Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391–420
Wasnich RD, Bagger YZ, Hosking DJ, McClung MR, Wu M, Mantz AM (2004) Changes in bone density and turnover after alendronate or estrogen withdrawal. Menopause 11:622–630
Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM (2013) The clinical utility of bone marker measurements in osteoporosis. J Transl Med 11:201
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This experiment was accomplished under the approval of the State Committee on Animal Ethics, Shiraz University, Shiraz, Iran. The recommendations of European Council Directive (86/609/EC) of November 24, 1986, regarding the standards in the protection of animals used for experimental purposes were also followed.
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Nikahval, B., Nazifi, S., Heidari, F. et al. Evaluation of the changes of P1NP and CTX in synovial fluid and blood serum of dogs with experimental osteoarthritis. Comp Clin Pathol 25, 559–563 (2016). https://doi.org/10.1007/s00580-016-2229-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-016-2229-x